Helping Pharmas Manage Compliance Risks for Speaker Programs

Size: px
Start display at page:

Download "Helping Pharmas Manage Compliance Risks for Speaker Programs"

Transcription

1 COGNIZANT Helping Pharmas Manage Compliance Risks for Speaker Programs By taking a rigorous and thoughtful approach that pivots around key performance indicators, pharmaceuticals companies can proactively identify and solve noncompliance challenges with speaker programs before they impact the bottom line. Cognizant Insights February 2017

2 Executive Summary Among the many promotional and marketing strategies used by pharmaceuticals companies, one of the most widely used and necessary components in the industry is the speaker program event. Pharma companies typically use peer-to-peer speaker programs to promote and educate healthcare professionals (HCPs) about their drug therapies and the diseases their drugs treat. The interactions between HCPs through such events not only affect prescribing patterns but also help HCPs stay up-to-date on the latest molecules, newly approved drug indications, the latest clinical data and safety issues, among many other things. But over the past few years, speaker program events have become a bone of contention in the industry as they tend to be misused. For example, some programs have provided opportunities for pharma companies to promote off label use of their drugs, which is illegal. In such instances, companies have been heavily penalized - and in some cases the resultant fines are estimated to be billions of dollars. As a result, multiple rules and regulations have been enacted by various U.S. government bodies, trade associations, and pharmaceuticals companies themselves, to ensure program compliance. This white paper examines key rules and regulations surrounding speaker programs and provides an overview of how we believe pharma companies can proactively identify and solve noncompliance challenges before they impact the bottom line.

3 Figure 1. Layers of Speaker Program Compliance Pharma companies conduct speaker program events for which they use SMEs to present approved educational materials to medical and associated professionals. These speaker programs must adhere to specific rules and regulations which are set by the government, trade organizations, and internally - as shown, respectively, below. Office of Inspector General Corporate Integrity Agreement Physician Payments Sunshine Act Code on Interactions with Health Care Professionals Office of Ethics and Compliance Financial Compliance Team Legal Office Sales & Marketing Operations DECONSTRUCTING SPEAKER PROGRAMS A speaker program event typically consists of one or more speakers, multiple attendees and the company representative who is responsible for arranging the program venue, topic and speaker. Speakers: Speakers at such events are typically subject matter experts (SMEs) approved by the company s internal review organization who have credentials and have undergone speaker training. They can be HCPs (national, regional and/or local key opinion leaders) or non-hcps (business or best-practice experts). Speakers are paid a fee for service based on fair market value (FMV) determined by their credentials. Attendees: Attendees are primarily HCPs (prescribers, nurses, technicians, etc.) or non-hcps (office staff, patients), and their medical specialty must correspond with the topic of the speaker program. Attendees are typically provided a meal at these events as a courtesy for their time. Topic: Presentation materials used must be compliant and reviewed by the U.S. Food and Drug Administration (FDA). Material can consist of the benefits, safety and usage of the product, or the diseases it treats, or it can be completely unrelated to the product. The speaker must present all the material provided; any modifications made should be approved before the material is presented. Helping Pharmas Manage Compliance Risks for Speaker Programs 3

4 CONSEQUENCES OF NONCOMPLIANCE During the past nine years, 10 of the world s major pharmaceuticals companies have been penalized a combined $12.9 billion by the government (see Figure 2) and are now operating under a corporate integrity agreement (CIA) for violating speaker program rules enforced by the Office of Inspector General (OIG). CIAs typically last five years and make corporate officers personally liable for the company s compliance with stipulations set forth by the CIA. These agreements usually require the following: Hire a compliance officer/appoint a compliance committee. Develop written standards and policies. Implement a comprehensive employee training program. Retain an independent review organization to conduct annual reviews. Report overpayments, reportable events and ongoing investigations/legal proceedings. Provide an implementation report and annual reports to U.S. OIG on the status of the entity s compliance activities. A part of the Affordable Care Act (ACA) known as the Physician Payments Sunshine Act covers physician financial transparency reports. This legislation requires manufacturers of drugs, medical devices and biologicals that participate in U.S. federal health care programs to report certain payments and items of value given to physicians and teaching hospitals. The Pharmaceutical Research and Manufacturers of America (PhRMA) is a U.S. industry trade group that represents pharmaceuticals research and biopharmaceuticals companies and advocates for public policies that encourage the discovery of new medicines for patients. They have codified rules concerning interactions with HCPs for the trade group s members to abide by. (The Figure 2. Financial Consequences for Noncompliance with a Blockbuster Drug GlaxoSmithKline $3 Bn Pfizer $2.3 Bn Johnson & Johnson $2.2 Bn AbbVie $1.5 Bn Eli Lilly $1.4 Bn Merck $950 Mn Amgen $762 Mn AstraZeneca $520 Mn Sanofi- Aventis $109 Mn Boehringer Ingelheim $95 Mn Penalties levied by the Office of Inspector General on each company during recent years. Helping Pharmas Manage Compliance Risks for Speaker Programs 4

5 Figure 3. A Framework for Speaker Program Compliance Vendor Data Client Data Expenses Speaker Information Specialty Data Attendee Information RSVP Data Budget Data Contract Information Attestation Data Topic Information Food Ordered Info Compliance RSVP Requirement Honoraria for Cancelled Programs Guideline Attendee Frequency Efficiency Material Management Allowable Meal Limit Approved Specialty Monitoring Speaker Attendance Speaker Bureau Management Aggregate Spend Analysis Annual Plan Monitoring Meal Consumption Program Costs Speaker Contract Confirmation Attestation Questions F&B Management Attendee Summary Transparency of speaker paym Programs with high catering expenses Speakers who are paid incorre honoraria Attendees attending the same topic multiple times Speakers without a contract Programs without attendees HCPs who promote off-label u of drugs Speakers with an expiring cont Speakers attending programs the same topics they spoke on Percent of topics unutilized Programs where F&B ordered less than the number of attend Percent of speakers unutilized Planned vs. actual peer-to-peer speaker programs are considered a form of interaction with HCPs.) As mentioned above, companies that have a CIA are also required to hire a compliance officer and/or appoint a compliance committee. These entities must set company policies to prevent inappropriate engagements as well as to preempt any activity that could be perceived as misconduct. IDENTIFYING NONCOMPLIANCE Our solution proposed in Figure 3 not only helps to identify cases of noncompliance but will also help a pharma company to more efficiently manage speaker programs, in turn making them more effective. It will also enable the company to identify the gaps in its compliance systems and processes and help it define the guidelines required to close them. Our process involves, initially, defining or identifying the various metrics or key performance indicators (KPIs). These KPIs would be based on the relevant laws, regulations, policies, standards, procedures or contractual obligations to which the organization must conform. These include the CIA, the Sunshine Act, the PhRMA code on interactions with HCPs, and the pharma company s own internal regulations and guidelines, among others. Some of the compliance areas covered are the following: Transparency of speaker payments: All expenses paid to speakers and other transfers of value (i.e., meals) can be tracked for each individual speaker in a calendar year. This can be tied to the type of program (lunch/dinner/ teleconference), the number of times each speaker presented, the number of attendees, whether the program took place or not (to Helping Pharmas Manage Compliance Risks for Speaker Programs 5

6 According to a company s CIA, it must submit annual plans that identify the business needs for various publication activities (including speaker programs) and the estimated numbers of such activities. monitor potential kickbacks) and brandrelated information. Excessive expenses (hotel, airfare, etc.) can be identified and new rules can be set to prevent further risks. This would be in accordance with a CIA as well as the Sunshine Act. Excessive value of company-provided meals: This would satisfy transparency and PhRMA guidelines, which stipulate that each meal should be of nominal value and is provided as a courtesy. Importantly, it should not be used to influence an attendee or a speaker. Signed contract confirmation: For every speaker program, a statement of work (SOW) or contract must be signed between the speaker and the organization that details the speaker s fee-for-service, expenses, topic to be covered, etc. Approved specialty monitoring: To prevent the promotion of off-label use of its drugs, companies must ensure that attendees are appropriate to the topic presented. The approved specialty is usually determined by FDA parameters covered in the speaker program. RSVPs: To ensure that the event has a minimum number of attendees apart from the speakers and reps, speaker programs are required to have a minimum number of RSVPs a few hours prior to the event. The minimum number may vary based on the event type. Annual plan monitoring: According to a company s CIA, it must submit annual plans that identify the business needs for various publication activities (including speaker programs) and the estimated numbers of such activities. The plans also identify the budgeted amounts to be spent on such activities. Speaker bureau size, number of programs and amount spent on programs are tracked. Meal consumption: Companies are allowed to provide a nominal meal as a courtesy to the attendees and speakers for participating in a speaker program. They will set limits on frequency of meals consumed by attendees to avoid the perception of the meal serving as a kickback. In addition, reporting on the meals consumed will be utilized for transparency of payments and transfer of value to HCPs (attendees and speakers). Food and beverage management: When speaker programs are held in a physician s office, the meals provided are intended for only those individuals who attend the speaker program. HCPs at the physician s office not Helping Pharmas Manage Compliance Risks for Speaker Programs 6

7 attending the speaker program are not permitted to receive food intended for attendees (i.e., distribution of leftovers is not permitted). So, the amount of food ordered should not exceed the requirements for the number of actual attendees or other parameters set forth by the company, such as RSVPs. Speaker bureau management: Companies can track the frequency of speaker utilization (national/regional/local key opinion leader (KOL) and non-kol), average attendance size per speaker, attendee mix per speaker (doctor, physician s assistant, etc.), speakers with expiring contracts, etc. Presentation decks management: Companies can track the frequency of utilization, average number of attendees per topic, average attendee mix (doctor, physician s assistant, etc.), expiring topics, etc. Attendee summary: Companies can track the number of attendees by program type (inoffice, out-of-office or teleconference), attendee category, etc. Speaker program costs summary: Speaker program-related expenses can be tracked for better budget management. Expenses can be categorized into expense types, such as speaker expenses (honoraria, travel, meals, etc.), pass-through costs (A/V costs, room rentals, management fees, etc.) and catering. These expenses can also be viewed by program type. Helping Pharmas Manage Compliance Risks for Speaker Programs 7

8 ABOUT THE AUTHOR Bill Restrepo Senior Associate Bill Restrepo is a Senior Associate within Cognizant s Analytics & Information Management Practice. He has over 15 years of experience in data analysis/analytics (the past four with Cognizant). Prior to Cognizant, Bill worked for companies in the life sciences, medical devices and scientific equipment industries. While at Cognizant, he has worked on projects for multiple pharmaceuticals clients. Bill has a bachelor s degree from the University of Illinois Urbana-Champaign. He can be reached at Guillermo.Restrepo@cognizant.com. ACKNOWLEDGMENTS The author would like to thank Navin Vipin for his contributions to this white paper. Helping Pharmas Manage Compliance Risks for Speaker Programs 8

9 ABOUT COGNIZANT Cognizant (NASDAQ-100: CTSH) is one of the world s leading professional services companies, transforming clients business, operating and technology models for the digital era. Our unique industry-based, consultative approach helps clients envision, build and run more innovative and efficient businesses. Headquartered in the U.S., Cognizant is ranked 230 on the Fortune 500 and is consistently listed among the most admired companies in the world. Learn how Cognizant helps clients lead with digital at or follow World Headquarters 500 Frank W. Burr Blvd. Teaneck, NJ USA Phone: Fax: Toll Free: European Headquarters 1 Kingdom Street Paddington Central London W2 6BD England Phone: +44 (0) Fax: +44 (0) India Operations Headquarters #5/535 Old Mahabalipuram Road Okkiyam Pettai, Thoraipakkam Chennai, India Phone: +91 (0) Fax: +91 (0) Copyright 2017, Cognizant. All rights reserved. No part of this document may be reproduced, stored in a retrieval system, transmitted in any form or by any means,electronic, mechanical, photocopying, recording, or otherwise, without the express written permission from Cognizant. The information contained herein is subject to change without notice. All other trademarks mentioned herein are the property of their respective owners. TL Codex 2435

Content as a Service

Content as a Service Offering Brief Content as a Service Ensure your customers create compelling and relevant content, improving brand experience with Cognizant Interactive s Content as a Service. Simplify and streamline your

More information

Transform your life and annuities business to reduce expenses and promote business growth.

Transform your life and annuities business to reduce expenses and promote business growth. LifeAdmin Core Overview Transform your life and annuities business to reduce expenses and promote business growth. December 2017 Business growth needs to happen simultaneously with cost cutting and support

More information

How to pivot your silo-based manufacturing operations to a more integrated framework capable of dealing with new requirements for mass customization.

How to pivot your silo-based manufacturing operations to a more integrated framework capable of dealing with new requirements for mass customization. ONEPLANT OVERVIEW How to pivot your silo-based manufacturing operations to a more integrated framework capable of dealing with new requirements for mass customization. December 2017 ONEPLANT OVERVIEW Are

More information

Reimagining content value to deliver personalized experiences and drive growth.

Reimagining content value to deliver personalized experiences and drive growth. CONTENTIZE OVERVIEW Reimagining content value to deliver personalized experiences and drive growth. December 2017 In an age of high customer expectations for a relevant experience, content reigns supreme.

More information

Minimize Returns, Maximize Recovery: Reverse Logistics Made Easy and Simple

Minimize Returns, Maximize Recovery: Reverse Logistics Made Easy and Simple Solution Overview Returns Minimize Returns, Maximize Recovery: Reverse Logistics Made Easy and Simple Make returns a strategic advantage for your retail or consumer goods organization. Reverse logistics

More information

Solution Overview. Cognizant Delivers Submission as a Service for Commercial New Business Submission Intake Process

Solution Overview. Cognizant Delivers Submission as a Service for Commercial New Business Submission Intake Process Cognizant Solution Overview Solution Overview Cognizant Delivers Submission as a Service for Commercial New Business Submission Intake Process Cognizant Solution Overview 2 Cognizant Delivers Submission

More information

Government Solutions for Today s Healthcare Challenges

Government Solutions for Today s Healthcare Challenges GOVERNMENT PROGRAMS Government Solutions for Today s Healthcare Challenges Health plans that serve the government programs healthcare market are presented with both challenges and opportunities. Having

More information

Front-to-back Architectural Re-design for a Global Universal bank

Front-to-back Architectural Re-design for a Global Universal bank CASE STUDY Front-to-back Architectural Re-design for a Global Universal bank Cognizant delivered a robust and scalable target architectural design aimed at improving operational efficiency and delivering

More information

Cognizant Solution Overview. Solution Overview. Cognizant and Measure Partner to Deliver a Dramatic Business Impact for Insurers Using Drones

Cognizant Solution Overview. Solution Overview. Cognizant and Measure Partner to Deliver a Dramatic Business Impact for Insurers Using Drones Solution Overview Cognizant and Measure Partner to Deliver a Dramatic Business Impact for Insurers Using Drones Cognizant Solution Overview Leverage drones technology to create industry leading solutions

More information

Value Stream Services

Value Stream Services Offering Overview Value Stream Services Ensure new offerings and transformed applications deliver their predicted business value and supercharge your digitally powered business velocity with Cognizant

More information

Digital Engineering: Top 5 Imperatives for Communications, Media and Technology Companies

Digital Engineering: Top 5 Imperatives for Communications, Media and Technology Companies DIGITAL BUSINESS Digital Engineering: Top 5 Imperatives for Communications, Media and Technology Companies Many companies share similar digital objectives. Here are our recommendations for realizing five

More information

What if one healthcare IT company is stronger than two?

What if one healthcare IT company is stronger than two? What if one healthcare IT company is stronger than two? To convey our unified, strategic focus on helping you answer healthcare s biggest challenges, TriZetto a member of the Cognizant family since 2014

More information

Transformation Enablement

Transformation Enablement Offering Overview Transformation Enablement Ensure your organization s digital transformation initiatives achieve radically different levels of performance and quickly capture value with Cognizant Digital

More information

DUCK CREEK POLICY UPGRADE FACTORY. Cognizant s Duck Creek Policy Upgrade Factory helps insurers transition to the latest version of Duck Creek Policy.

DUCK CREEK POLICY UPGRADE FACTORY. Cognizant s Duck Creek Policy Upgrade Factory helps insurers transition to the latest version of Duck Creek Policy. Approach Paper DUCK CREEK POLICY UPGRADE FACTORY Cognizant s Duck Creek Policy Upgrade Factory helps insurers transition to the latest version of Duck Creek Policy. Duck Creek Policy Upgrade Factory February

More information

Offering Overview. Change Adoption

Offering Overview. Change Adoption Offering Overview Change Adoption Ensure digital initiatives generate and sustain their promised business value and performance by accelerating adoption of new digital technologies, platforms and processes

More information

Breaking Tradition in ICD-10 Testing

Breaking Tradition in ICD-10 Testing Cognizant 20-20 Insights Breaking Tradition in ICD-10 Testing A nontraditional testing approach is required to successfully address ICD-10 s impact on business operations. Executive Summary In most cases,

More information

>ModelEye Solution Overview

>ModelEye Solution Overview >ModelEye Solution Overview 1 Enterprise-wide Model Risk Governance Platform Solution Overview Chief risk officers of all financial institutions are actively trying to manage model risk. As a fallout of

More information

Solution Overview. Transform your life and annuities business

Solution Overview. Transform your life and annuities business Solution Overview Transform your life and annuities business Reduce operations expenses with Cognizant s business process as a service offering. Solution Overview: Is your legacy a burden rather than an

More information

Speeding Human- Centered Technology to Market

Speeding Human- Centered Technology to Market Solution Overview Digital Engineering Speeding Human- Centered Technology to Market On-site ethnographic research puts you in your customers shoes, and their hearts. Hyper agile development turns those

More information

Making Life Easier for Investigators: A Shared Solution for Smarter, Faster Clinical Trials

Making Life Easier for Investigators: A Shared Solution for Smarter, Faster Clinical Trials Cognizant 20-20 Insights Making Life Easier for Investigators: A Shared Solution for Smarter, Faster Clinical Trials The industry s Shared Investigator Platform significantly reduces the time and cost

More information

Greenfield Application Solution

Greenfield Application Solution Offering Overview Greenfield Application Solution Be first to market and realize business value quickly from major new product, service and experience introductions with Greenfield Application Solution

More information

Improving Clinical Trial Patient Retention Using Cognizant s HealthActivate Patient Engagement Solution

Improving Clinical Trial Patient Retention Using Cognizant s HealthActivate Patient Engagement Solution Improving Clinical Trial Patient Retention Using Cognizant s HealthActivate Patient Engagement Solution HealthActivate Life Sciences companies are under increasing pressure to reduce clinical trial costs,

More information

ICD-10 Advantages Require Advanced Analytics

ICD-10 Advantages Require Advanced Analytics Cognizant 20-20 Insights ICD-10 Advantages Require Advanced Analytics Compliance alone will not deliver on ICD-10 s potential to improve quality of care, reduce costs and elevate efficiency. Organizations

More information

Solution Overview Connected Places

Solution Overview Connected Places Connected Places Buildings are getting smart. Are you optimizing facilities management to save money, improve operations, and enhance customer experience? If not, it s time. March 2019 Facilities don t

More information

A Strategic Approach to CMO Serialization Compliance

A Strategic Approach to CMO Serialization Compliance COGNIZANT 20-20 INSIGHTS A Strategic Approach to CMO Serialization Compliance Pharmaceuticals companies must address the risk of supply chain disruptions related to products requiring serialization to

More information

Cognizant Digital Engineering: Accelerate Application Transformation for the Cloud

Cognizant Digital Engineering: Accelerate Application Transformation for the Cloud Cognizant Digital Engineering: Accelerate Application Transformation for the Cloud More Value, Faster Velocity In the digital economy, the advantage goes to the company that can deliver high-value software

More information

Corporate Overview. Helping clients win with digital at scale and speed

Corporate Overview. Helping clients win with digital at scale and speed Corporate Overview Helping clients win with digital at scale and speed Corporate Overview 1 Cognizant (NASDAQ-100: CTSH) is one of the world s leading professional services companies, transforming clients

More information

Cognizant BigFrame Fast, Secure Legacy Migration

Cognizant BigFrame Fast, Secure Legacy Migration Cognizant BigFrame Fast, Secure Legacy Migration Speeding Business Access to Critical Data BigFrame speeds migration from legacy systems to secure next-generation data platforms, providing up to a 4X performance

More information

CASS Governance Implementation for a Global Universal Bank

CASS Governance Implementation for a Global Universal Bank CASE STUDY CASS Governance Implementation for a Global Universal Bank Cognizant led a multi-disciplinary team to develop a robust, tailored and scalable solution framework to manage and safeguard client

More information

CIO Priorities: Striking the Right Balance Between Growth and Efficiency

CIO Priorities: Striking the Right Balance Between Growth and Efficiency Cognizant 20-20 Insights CIO Priorities: Striking the Right Balance Between Growth and Efficiency As a slowdown looms, Indian financial firms CIOs are turning to technology to rein in costs without hampering

More information

Digital Field Services Improves Performance & Up-Time

Digital Field Services Improves Performance & Up-Time SOLUTION OVERVIEW Digital Field Services Improves Performance & Up-Time The sensor for a fuel pump in a commercial airliner flashes a warning. The fault could cause failure, but the airline is forewarned

More information

CONNECTED PRODUCTS OVERVIEW. Connected Products

CONNECTED PRODUCTS OVERVIEW. Connected Products CONNECTED PRODUCTS OVERVIEW Connected Products How to redefine next generation product development that creates high-quality, connected products faster while controlling costs and delivering on customer

More information

Offering Overview. Managed Innovation

Offering Overview. Managed Innovation Offering Overview Managed Innovation Companies must align innovation with a deep understanding of what consumers want to bring new experiences to market that deliver and capture value. Managed Innovation

More information

Asset Finance & Leasing: Navigating the Pivot to Digital

Asset Finance & Leasing: Navigating the Pivot to Digital COGNIZANT 20-20 INSIGHTS Asset Finance & Leasing: Navigating the Pivot to Digital Asset finance and leasing companies need to look beyond technology and consider fundamental strategic questions about how

More information

Cognizant Digital Media Services: One partner for all your content needs

Cognizant Digital Media Services: One partner for all your content needs Cognizant Solutions Overview Cognizant Digital Media : One partner for all your content needs is the new business driver It s engaging your audiences and opening new revenue opportunities. And it puts

More information

Guide to North America Healthcare Compliance 2016/2017

Guide to North America Healthcare Compliance 2016/2017 Guide to North America Healthcare Compliance 2016/2017 Dr. Reddy s Laboratories, Inc. NOTICE: this information is provided pursuant to the requirements of California Health & Safety Code 119400, 119402,

More information

Diagramming Change to Better Inform Business Process Renovation

Diagramming Change to Better Inform Business Process Renovation Cognizant 20-20 Insights Diagramming Change to Better Inform Business Process Renovation To gain the full benefits of business process management, banks must apply a business process model and notation-driven

More information

Off-label, Anti-Kickback, and Other Risks within Speaker Program Compliance

Off-label, Anti-Kickback, and Other Risks within Speaker Program Compliance Off-label, Anti-Kickback, and Other Risks within Speaker Program Compliance Neal J. Rafferty US Compliance Officer Merz North America neal.rafferty@merz.com The content & statements in this presentation

More information

Shaping a Three-Layered Intended Strategy to Realize Benefits for Life Sciences R&D Site Closures

Shaping a Three-Layered Intended Strategy to Realize Benefits for Life Sciences R&D Site Closures Cognizant 20-20 Insights Shaping a Three-Layered Intended Strategy to Realize Benefits for Life Sciences R&D Site Closures To ensure minimal disruption and impact to regular business operations, leadership

More information

Expand your automation horizon and your returns with Cognizant s comprehensive intelligent automation solutions

Expand your automation horizon and your returns with Cognizant s comprehensive intelligent automation solutions Offering Overview Digital Operations Intelligent Process Automation Expand your automation horizon and your returns with Cognizant s comprehensive intelligent automation solutions Scale and Mature Your

More information

COMPETE IN THE DIGITAL ECONOMY WITH APPLICATION MODERNIZATION FROM COGNIZANT

COMPETE IN THE DIGITAL ECONOMY WITH APPLICATION MODERNIZATION FROM COGNIZANT ModernizeIT: Apps & Infra Integrated Transformation COMPETE IN THE DIGITAL ECONOMY WITH APPLICATION MODERNIZATION FROM COGNIZANT Equipping the Enterprise for Digital Success In today s always-on digital

More information

TriZetto QicLink Enterprise TM

TriZetto QicLink Enterprise TM Brochure TriZetto QicLink Enterprise TM Succeeding in today s demanding healthcare market requires a core claims administration system that can accommodate benefits management strategies that are continuously

More information

Compliance on the Road: Government and Industry Efforts to Monitor Field Force

Compliance on the Road: Government and Industry Efforts to Monitor Field Force Page 1 of 6 May 2011 Volume 7 Number 9 Compliance on the Road: Government and Industry Efforts to Monitor Field Force Compliance By Heather McCollum, Senior Consultant, Polaris Management Partners, New

More information

Program Coordinator Medication Assistance Program Smilow Cancer Hospital at Yale New Haven

Program Coordinator Medication Assistance Program Smilow Cancer Hospital at Yale New Haven Program Coordinator Medication Assistance Program Smilow Cancer Hospital at Yale New Haven Yale MAP Program Consists of 5 FTE s Has been established for five years Was originally mirrored from the Ohio

More information

THE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 118 PATIENT GROUPS with an interest in RESPIRATORY CONDTIONS

THE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 118 PATIENT GROUPS with an interest in RESPIRATORY CONDTIONS THE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 118 PATIENT GROUPS with an interest in RESPIRATORY CONDTIONS PUBLISHED OCTOBER 2016 [Question to respondents: Which companies have the best record

More information

Auditing: A Panel Discussion of Evolving Compliance Strategies

Auditing: A Panel Discussion of Evolving Compliance Strategies Auditing: A Panel Discussion of Evolving Compliance Strategies Ann E Lewis, VP and Senior Counsel, US Healthcare Law Compliance (Bristol-Myers Squibb) Monica Jonhart, Director, Auditing, US Healthcare

More information

GSE Loan Delivery: Interim Analysis and Approach

GSE Loan Delivery: Interim Analysis and Approach Cognizant 20-20 Insights GSE Loan Delivery: Interim Analysis and Approach Executive Summary While the recent housing crisis can be attributed to a number of factors low interest rates, exotic products,

More information

Retail Analytics: Game Changer for Customer Loyalty

Retail Analytics: Game Changer for Customer Loyalty Cognizant 20-20 Insights Retail Analytics: Game Changer for Customer Loyalty By leveraging analytics tools and models, retailers can boost customer loyalty by creating a personalized shopping experience

More information

China Compliance Roundtable RDPAC Legal and Compliance Working Group Best Practices Task Force

China Compliance Roundtable RDPAC Legal and Compliance Working Group Best Practices Task Force China Compliance Roundtable RDPAC Legal and Compliance Working Group Best Practices Task Force September 11, 2012 Agenda 1. Status Report the RDPAC Code 2. Emerging Trends China 2012 1. General 2. T&E

More information

Beyond the Cloud: Reaching for Stratospheric Heights of Accelerated Business

Beyond the Cloud: Reaching for Stratospheric Heights of Accelerated Business Beyond the Cloud: Reaching for Stratospheric Heights of Accelerated Business How to leverage cloud better and faster than the competition as you race toward digital transformation and business innovation

More information

Seven Steps to Quickly Develop Software that Delivers Customer Value

Seven Steps to Quickly Develop Software that Delivers Customer Value DIGITAL BUSINESS Seven Steps to Quickly Develop Software that Delivers Customer Value These field-tested steps can help organizations make the required changes to speed software to market that meets continuously

More information

Coordinating Security Response and Crisis Management Planning

Coordinating Security Response and Crisis Management Planning Cognizant 20-20 Insights Coordinating Security Response and Crisis Management Planning Proper alignment of these two critical IT disciplines can mean the difference between an efficient response and a

More information

Real-World Evidence: A Better Life Journey for Pharmas, Payers and Patients

Real-World Evidence: A Better Life Journey for Pharmas, Payers and Patients Cognizant 20-20 Insights Real-World Evidence: A Better Life Journey for Pharmas, Payers and Patients Using RWE, the entire healthcare ecosystem can use actual health outcomes to better assess the value

More information

EXAMINE THE BREAKDOWN OF FEES IN MANAGED MARKETS AND SPECIALTY PHARMACIES

EXAMINE THE BREAKDOWN OF FEES IN MANAGED MARKETS AND SPECIALTY PHARMACIES EXAMINE THE BREAKDOWN OF FEES IN MANAGED MARKETS AND SPECIALTY PHARMACIES CBI 4TH ANNUAL FMV CONGRESS March 28, 2017 2017 HURON CONSULTING GROUP INC. SPEAKER INTRODUCTIONS John Moose, CPA, ABV Director

More information

Applying Predictive Analytics to Deliver Smart Power Outage Communications

Applying Predictive Analytics to Deliver Smart Power Outage Communications COGNIZANT 0-0 INSIGHTS Applying Predictive Analytics to Deliver Smart Power Outage Communications By building proactive outage communication that provides accurate, detailed and realtime outage statuses

More information

THE TOP 5 TRENDS IN HCP S DIGITAL PREFERENCE. PHARMAFUTURE. All rights reserved.

THE TOP 5 TRENDS IN HCP S DIGITAL PREFERENCE. PHARMAFUTURE. All rights reserved. THE TOP 5 TRENDS IN HCP S DIGITAL PREFERENCE DISCLAIMER All findings, inferences, and data shared in this report are solely the views of the respondents and may, or may not represent the views of any

More information

From Continuous to Autonomous Testing with AI

From Continuous to Autonomous Testing with AI COGNIZANT 20-20 INSIGHTS From Continuous to Autonomous Testing with AI Continuous testing, or DevOps embedded with QA, helps organizations keep pace with market dynamics. Artificial intelligence can augment

More information

BACK-OFFICE TRANSFORMATION OF A GLOBAL INVESTMENT BANK

BACK-OFFICE TRANSFORMATION OF A GLOBAL INVESTMENT BANK CASE STUDY Banking & Financial Services BACK-OFFICE TRANSFORMATION OF A GLOBAL INVESTMENT BANK Business Situation Investment banks today face a multitude of business and operational challenges. Apart from

More information

Benchmarking Compliance Programs. Bret S. Bissey, MBA, FACHE, CHC, CMPE, Senior Vice President, Compliance Services, MediTract

Benchmarking Compliance Programs. Bret S. Bissey, MBA, FACHE, CHC, CMPE, Senior Vice President, Compliance Services, MediTract Benchmarking Compliance Programs Bret S. Bissey, MBA, FACHE, CHC, CMPE, Senior Vice President, Compliance Services, MediTract Health Care Compliance Association INDIANAPOLIS, IN Regional Conference September

More information

Using Predictive Analytics to Optimize Asset Maintenance in the Utilities Industry

Using Predictive Analytics to Optimize Asset Maintenance in the Utilities Industry Cognizant 20-20 Insights Using Predictive Analytics to Optimize Asset Maintenance in the Utilities Industry By working proactively to collect and distill digital information, transmission and distribution

More information

Cognizant and Duck Creek Helping P&C insurers accelerate business transformation

Cognizant and Duck Creek Helping P&C insurers accelerate business transformation Duck Creek Practice Overview Cognizant and Duck Creek Helping P&C insurers accelerate business transformation Property and casualty (P&C) insurance is an old business. Some historians trace the origins

More information

THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (SPANISH EDITION)

THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (SPANISH EDITION) THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (SPANISH EDITION) Feedback from 108 Spanish patient groups PUBLISHED MAY 2016 Nuevos tratamientos con precios que impidan el acceso para

More information

Integrated Mobility QA: A Strategic Business Enabler for Enhancing End-user Experience Across Digital Channels

Integrated Mobility QA: A Strategic Business Enabler for Enhancing End-user Experience Across Digital Channels Cognizant 20-20 Insights Integrated Mobility QA: A Strategic Business Enabler for Enhancing End-user Experience Across Digital Channels As smartphones and tablets enter the market at breakneck speed, organizations

More information

Operational Considerations for Transparency. September 2011

Operational Considerations for Transparency. September 2011 Operational Considerations for Transparency September 2011 Current Global Regulatory Trends Type of Regulations/ Guidance Company s obligations Scope Sanctions/ Penalties State Laws Promotional spend reporting

More information

Elevation Virtual Meeting Speaker Programs Case Study: Launching Two New Brands

Elevation Virtual Meeting Speaker Programs Case Study: Launching Two New Brands Elevation Virtual Meeting Speaker Programs Case Study: Launching Two New Brands SITUATION In the second half of 2013, a Top Ten biopharmaceutical company received FDA approval for two new brands in the

More information

New Trends in the Use of Fair Market Value Concepts. PCF Disclosure, Transparency, and Aggregate Spend Conference February 6, 2014

New Trends in the Use of Fair Market Value Concepts. PCF Disclosure, Transparency, and Aggregate Spend Conference February 6, 2014 New Trends in the Use of Fair Market Value Concepts PCF Disclosure, Transparency, and Aggregate Spend Conference February 6, 2014 Agenda Today s Speakers 4 Today s Discussion Topics 6 Question and Answer

More information

THE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 199 PATIENT GROUPS with an interest in RARE DISEASES

THE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 199 PATIENT GROUPS with an interest in RARE DISEASES THE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 199 PATIENT GROUPS with an interest in RARE DISEASES PUBLISHED MAY 2016 Dans notre domaine de maladies rares où des efforts ont été faits pour

More information

Missing the Mark: Ten Reasons Why Automation Fails Across the Software Development Lifecycle

Missing the Mark: Ten Reasons Why Automation Fails Across the Software Development Lifecycle DIGITAL SYSTEMS & TECHNOLOGY Missing the Mark: Ten Reasons Why Automation Fails Across the Software Development Lifecycle Automation is the foundation for success in the digital age. However, as organizations

More information

A Next-Generation Approach to Integrated Warranty Management

A Next-Generation Approach to Integrated Warranty Management Cognizant 20-20 Insights A Next-Generation Approach to Integrated Warranty For today s manufacturers, gaining actionable insights from customers warranty data requires a closed-loop system that pivots

More information

WORKSHOP B Monitor MSL and Field Force Compliance

WORKSHOP B Monitor MSL and Field Force Compliance WORKSHOP B Monitor MSL and Field Force Compliance Jeremy Lutsky Sr. Legal & Compliance Counsel Theravance Biopharma US, Inc. Alison Benincasa Associate Director, Specialty Markets Compliance Christine

More information

Sunshine Act and Beyond: Improving Policies and Strategies

Sunshine Act and Beyond: Improving Policies and Strategies Helping companies identify and manage their compliance and commercial risk. C O M P L I A N C E IMPLEMENTATION SERVICES Sunshine Act and Beyond: Improving Policies and Strategies Presented by Vahan Minassian,

More information

GIFTS, GRATUITIES AND BUSINESS COURTESIES

GIFTS, GRATUITIES AND BUSINESS COURTESIES GIFTS, GRATUITIES AND BUSINESS COURTESIES Policy Statement This policy is intended to provide guidance for appropriate decision- making regarding the Acceptance, solicitation and/or provision of gifts

More information

Allergan plc COMPREHENSIVE COMPLIANCE PROGRAM

Allergan plc COMPREHENSIVE COMPLIANCE PROGRAM Allergan plc COMPREHENSIVE COMPLIANCE PROGRAM 1. Compliance with Law All colleagues, officers and directors of the Company shall respect and comply with all applicable federal, state, local and foreign

More information

THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (NORDIC EDITION)

THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (NORDIC EDITION) THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (NORDIC EDITION) Feedback from 147 Nordic patient groups PUBLISHED JUNE 2016 Syöpälääkkeiden kehitys on ollut hyvä, ja yhä useammat paranevat.

More information

PRECONFERENCE: AGGREGATE SPEND AND DISCLOSURE 101

PRECONFERENCE: AGGREGATE SPEND AND DISCLOSURE 101 PRECONFERENCE: AGGREGATE SPEND AND DISCLOSURE 101 The Basics of Disclosure/Aggregate Spend Technology Solutions Don Soong Sr Director, Compliance Solutions Cegedim March 9 th, 2011 THIS IS THE INTRODUCTION

More information

Declaration Pursuant to California Health and Safety Code (e)

Declaration Pursuant to California Health and Safety Code (e) Declaration Pursuant to California Health and Safety Code 119402(e) Bausch + Lomb is committed to upholding the highest standards of business conduct and ethics in its relationships with its customers,

More information

How Agile Application Portfolio Rationalization Delivers Digital Success

How Agile Application Portfolio Rationalization Delivers Digital Success COGNIZANT 20-20 INSIGHTS How Agile Application Portfolio Rationalization Delivers Digital Success Frequent tweaks based on user feedback can help IT provide the right mix of applications with the least

More information

Audit Preparation and SOP s Pharma Forum Lisa Keilty, CMP HCC

Audit Preparation and SOP s Pharma Forum Lisa Keilty, CMP HCC Audit Preparation and SOP s Pharma Forum 2013 Lisa Keilty, CMP HCC 1 Audit: A Component of Compliance OIG identifies: 7 Core Elements of an Effective Compliance Program Written policies and procedures

More information

Speaker Programs Risks and Rewards. Presented by: Alan G. Minsk Partner, Arnall Golden Gregory LLP and Alliance Legal Counsel

Speaker Programs Risks and Rewards. Presented by: Alan G. Minsk Partner, Arnall Golden Gregory LLP and Alliance Legal Counsel Speaker Programs Risks and Rewards Presented by: Alan G. Minsk Partner, Arnall Golden Gregory LLP and Alliance Legal Counsel alan.minsk@agg.com What is a Speaker Program! Company-Sponsored Program! Typically,

More information

Speaker Programs February 8, 2017 Shauna C. Liu Richard F. Eschle, Pharm.D., J.D.

Speaker Programs February 8, 2017 Shauna C. Liu Richard F. Eschle, Pharm.D., J.D. Speaker Programs 2017 February 8, 2017 Shauna C. Liu Richard F. Eschle, Pharm.D., J.D. 1 Disclaimer The opinions expressed in this presentation are mine and do not necessarily reflect of those of my employer.

More information

Compliance Plans. Kelly S. McIntosh July 20, 2017

Compliance Plans. Kelly S. McIntosh July 20, 2017 Compliance Plans Kelly S. McIntosh July 20, 2017 Roadmap The importance of compliance and compliance programs Common compliance issues know your risk areas! Guidance for drafting or updating your compliance

More information

Transformation to World Leading Quality: Is Your Organization Ready?

Transformation to World Leading Quality: Is Your Organization Ready? Cognizant 20-20 Insights Transformation to Quality: Is Your Organization Ready? As new technologies emerge and demand rises for faster time-to-market with the highest quality, QA organizations need to

More information

Strategic Cost Optimization: Driving Business Innovation While Reducing IT Costs

Strategic Cost Optimization: Driving Business Innovation While Reducing IT Costs Strategic Cost Optimization: Driving Business Innovation While Reducing IT Costs CIOs embrace strategic cost optimization initiatives by striking a balance between IT spend and investments in business

More information

Embracing Digital Convergence amid Regulatory-Driven Overhauls

Embracing Digital Convergence amid Regulatory-Driven Overhauls COGNIZANT 20-20 INSIGHTS Embracing Digital Convergence amid Regulatory-Driven Overhauls With the deadline for the EU s General Data Protection Regulation (GDPR) fast approaching, and other incoming regulations

More information

EFPIA codex on transparency of value exchange more sunshine or rain?

EFPIA codex on transparency of value exchange more sunshine or rain? Automotive the way we see it EFPIA codex on transparency of value exchange more sunshine or rain? How the EFPIA codex wil create new challenges for the industry Pharma needs to create transparency for

More information

Adaptable, Agile & Fast: Process Principles for Digital Business

Adaptable, Agile & Fast: Process Principles for Digital Business DIGITAL BUSINESS Adaptable, Agile & Fast: Process Principles for Digital Business As companies increase their reliance on digital technologies, they require highly flexible processes that span functional

More information

Rules of Engagement for MSLs - Appropriate Interactions with Internal and External Stakeholders

Rules of Engagement for MSLs - Appropriate Interactions with Internal and External Stakeholders Rules of Engagement for MSLs - Appropriate Interactions with Internal and External Stakeholders Daniel Snyder, PhD Medical Director, Neurology North America Medical Affairs Ipsen Biopharmaceuticals, Inc.

More information

2014 U.S. Trends in Aggregate Spend Disclosure and Transparency

2014 U.S. Trends in Aggregate Spend Disclosure and Transparency 2014 U.S. Trends in Aggregate Spend Disclosure and Transparency Results From Our 5th Annual Industry Survey Overview As of March 2014, manufacturers of drugs, medical devices, and medical supplies will

More information

THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EUROPE EDITION)

THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EUROPE EDITION) THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EUROPE EDITION) Feedback from 797 patient groups in Europe PUBLISHED APRIL 2016 The perception [of pharma] has changed in the last years,

More information

April New KOL Engagement: Building Relationships with the Digital KOL Generation ES SAMPLE PAGES SA. A FirstWord ExpertViews Dossier Report

April New KOL Engagement: Building Relationships with the Digital KOL Generation ES SAMPLE PAGES SA. A FirstWord ExpertViews Dossier Report A FirstWord ExpertViews Dossier Report Published Copyright 2016 Doctor s Guide Publishing Limited All rights reserved. No part of this publication may be reproduced or used in any form or by any means

More information

Realizing the National Health IT Strategy Through the Adoption of a Standardized Digital Identity Solution

Realizing the National Health IT Strategy Through the Adoption of a Standardized Digital Identity Solution Realizing the National Health IT Strategy Through the Adoption of a Standardized Digital Identity Solution Mollie Shields-Uehling SAFE-BioPharma Association SAFE-BioPharma Association Agenda Why do we

More information

COMBATING BRIBERY & CORRUPTION THROUGH INFORMATION INTELLIGENCE

COMBATING BRIBERY & CORRUPTION THROUGH INFORMATION INTELLIGENCE COMBATING BRIBERY & CORRUPTION THROUGH INFORMATION INTELLIGENCE SETTING THE CONTEXT Anti-bribery and corruption continues to be a high priority Sustained enforcement and increasing regulator expectations,

More information

Transparency as a Good Business Practice

Transparency as a Good Business Practice Transparency as a Good Business Practice Exploring How Transparency Can Drive Best Practices in Business Strategy August 2017 Polaris Management Partners Agenda Compliance Trends 2017-2018 Deriving Strategic

More information

Anderson Compliance Program

Anderson Compliance Program POLICY: Gifts, Gratuities and Business Courtesies 02/15 Anderson Compliance Program GIFTS, GRATUITIES, AND BUSINESS COURTESIES POLICY Purpose: The federal anti-kickback statute prohibits the acceptance

More information

MEASURING & MONITORING RISK USING ANALYTICS

MEASURING & MONITORING RISK USING ANALYTICS MEASURING & MONITORING RISK USING ANALYTICS APRIL 13, 2017 2017 HURON CONSULTING GROUP INC. PRESENTERS Brian Bohnenkamp Partner King & Spalding BBohnenkamp@KSLAW.com Jack Tanselle Managing Director Huron

More information

Data Management in the Footwear Industry

Data Management in the Footwear Industry Cognizant 20-20 Insights Data Management in the Footwear Industry By centralizing and integrating product information management with enterprise resource planning and shop floor execution systems, footwear

More information

Managing Conflicts of Interest in the Pharmaceutical Sector

Managing Conflicts of Interest in the Pharmaceutical Sector Managing Conflicts of Interest in the Pharmaceutical Sector Marc A. Rodwin, J.D., Ph.D. Professor of Law, Suffolk University Law School Boston, MA 02140, U.S.A. marcrodwin@gmail.com Implementing the access

More information

Optimizing the Impact of the Medical Affairs Function

Optimizing the Impact of the Medical Affairs Function Optimizing the Impact of the Medical Affairs Function Tim Dietlin, Vice President, Medical Affairs Practice Keith Morris, Practice Executive, Medical Affairs Practice Introduction The Medical Affairs function

More information

Pharmamarketing - strategic challenges

Pharmamarketing - strategic challenges Pharmamarketing - strategic challenges Biomedicine Master Program Lund University Course: Biomedicine the Profession Anna Chérouvrier Hansson, MSc. December 16th, 2014 1. Pharmamarketing - definitions

More information

ENABLING FRONT OFFICE TRANSFORMATION

ENABLING FRONT OFFICE TRANSFORMATION CASE STUDY ENABLING FRONT OFFICE TRANSFORMATION How Salesforce and a humancentered digital transformation approach accelerated Cognizant s marketing and sales In 2015, Cognizant Technology Solutions was

More information